MedPath

浙江家和制药有限公司

Ownership
-
Established
1995-08-17
Employees
-
Market Cap
-
Website
www.jiahezhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

Azithromycin Tablets

Product Name
阿奇霉素片
Approval Number
国药准字H20053834
Approval Date
Jun 23, 2020
NMPA

Gliclazide Capsules

Product Name
格列齐特胶囊
Approval Number
国药准字H33021350
Approval Date
Jun 23, 2020
NMPA

Fluconazole Capsules

Product Name
氟康唑胶囊
Approval Number
国药准字H20053565
Approval Date
Jun 23, 2020
NMPA

Erythromycin Ethylsuccinate Tablets

Product Name
琥乙红霉素片
Approval Number
国药准字H33021354
Approval Date
Jun 23, 2020
NMPA

Erythromycin Ethylsuccinate Tablets

Product Name
琥乙红霉素片
Approval Number
国药准字H33021355
Approval Date
Jun 23, 2020
NMPA

Erythromycin Ethylsuccinate Granules

Product Name
琥乙红霉素颗粒
Approval Number
国药准字H33021353
Approval Date
Jun 12, 2020
NMPA

Erythromycin Ethylsuccinate Granules

Product Name
琥乙红霉素颗粒
Approval Number
国药准字H33021352
Approval Date
Jun 12, 2020
NMPA

Aminophylline Bromhexine and Chlorphenamine Tablets

Product Name
茶新那敏片
Approval Number
国药准字H33021821
Approval Date
Jun 1, 2020
NMPA

Metronidazole and Vitamin B6 Tablets

Product Name
甲硝唑维B6片
Approval Number
国药准字H33022037
Approval Date
Jun 1, 2020
NMPA

元胡止痛胶囊

Approval Number
国药准字Z33020830
Approval Date
Jun 1, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.